Sales Nexus CRM

SOBRsafe Inc. Reports Significant Revenue Growth Driven by SOBRsure(TM) GEN 2 Sales

By Advos

TL;DR

SOBRsafe's Q2 2025 revenue surged 92.3% year-over-year, highlighting the competitive edge of its SOBRsure(TM) GEN 2 technology in the alcohol monitoring market.

SOBRsafe achieved a 57.5% gross margin and reduced net loss to $2.0 million, demonstrating efficient operational and financial management through its technology sales and subscriptions.

SOBRsafe's innovative alcohol detection technology promotes trust and recovery, offering dignified solutions that improve safety and well-being in behavioral health and family law sectors.

Discover how SOBRsafe's touch-based alcohol detection technology, requiring no breath or blood samples, is revolutionizing monitoring with a 109.6% increase in software subscription revenue.

Found this article helpful?

Share it with your network and spread the knowledge!

SOBRsafe Inc. Reports Significant Revenue Growth Driven by SOBRsure(TM) GEN 2 Sales

SOBRsafe Inc. (NASDAQ: SOBR), a pioneer in advanced alcohol monitoring and detection solutions, has reported a remarkable 92.3% year-over-year revenue growth in the second quarter of 2025, reaching $104,200. This surge is primarily attributed to the robust sales of its SOBRsure(TM) GEN 2 hardware and software, which accounted for 76.5% of the total revenue. The company also noted a 380 basis points improvement in gross margin, which rose to 57.5%, alongside a reduction in net loss to $2.0 million from $2.1 million in the same quarter the previous year.

The quarter saw SOBRsafe shipping 178 units of its SOBRsure(TM) GEN 2 devices, marking a 35.9% increase from the first quarter. Additionally, the company experienced a 109.6% year-over-year growth in annual recurring software subscription revenue, which now represents 55.2% of the quarterly revenue. These financial achievements underscore the growing demand for SOBRsafe's innovative alcohol detection technology.

Operational milestones during the quarter included the independent third-party validation of the SOBRsure(TM) GEN 2's performance, the launch of an enhanced B2B e-commerce platform, and the issuance of a European Patent for SOBRcheck(TM). Furthermore, SOBRsafe expanded its sales team and ventured into the Family Law market, signaling its commitment to broadening its market reach and application of its technology.

As of June 30, 2025, SOBRsafe reported cash and equivalents of $8.5 million, providing a solid foundation for future growth and innovation. The company's advancements in alcohol detection technology, which eliminates the need for breath, blood, or urine samples by detecting alcohol through the skin, represent a significant leap forward in monitoring and screening solutions. For more details on SOBRsafe's financial performance and technological innovations, visit https://ibn.fm/V6ahv.

blockchain registration record for this content
Advos

Advos

@advos